Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

InVivo Therapeutics Holdings Corp (NASDAQ:NVIV)

6.68
Delayed Data
As of May 27
 +0.28 / +4.37%
Today’s Change
3.50
Today|||52-Week Range
17.87
-7.22%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization366.9K740.7K752.0K689.0K
 
 
 
 
 
 
Operating ExpensesGross Income-366.9K-740.7K-752.0K-689.0K
 
 
 
 
 
General Expenses12.4M18.3M17.1M21.7M
 
 
 
 
 
Research And Development6.4M10.5M10.3M10.1M
 
 
 
 
 
Total Operating Expenses12.8M19.0M17.8M22.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-12.8M-19.0M-17.8M-22.4M
 
 
 
 
 
Extraordinary Credit17.5M----0.00
 
 
Extraordinary Charge0.00-19.6M-376.0K-10.8M
 
 
 
 
Interest Expense On Debt71.7K129.9K136.0K172.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income4.7M-38.8M-18.3M-33.3M
 
 
 
 
 
Net Income4.7M-38.8M-18.3M-33.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS15.8M18.5M22.1M26.5M
 
 
 
 
 
Shares To Calculate EPS Diluted18.0M18.5M22.1M26.5M
 
 
 
 
 
 
Earnings Per ShareEPS$0.24-$2.08-$0.84-$1.26
 
 
 
 
 
EPS Diluted$0.24-$2.08-$0.84-$1.26